The Lexington Addicts, 1971–1972: Demographic Characteristics, Drug Use Patterns, and Selected Infectious Disease Experience

References

• Biggam A. G. Malignant malaria associated with the administration of heroin intravenously. Trans. R. Soc. Trop. Med. Hyg. 1929; 23: 147–153
   Google Scholar
• Brown L. S., Murphy D. L., Primm B. J. Needle sharing and AIDS in minorities. J. Am. Med. Assoc. 1987; 258: 1474–1475
   PubMed Web of Science ®Google Scholar
• Brown S. M., Stimmel B., Taub R. N., Kochwa S., Rosenfield R. E. Immunological dysfunction in heroin addicts. Arch. Intern. Med. 1974; 134: 1001–1006
   PubMed Web of Science ®Google Scholar
• Chaisson R. E., Moss A. R., Onishi R., Osmond D., Carlson J. R. Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. Am. J. Public Health 1987; 77: 169–172
   PubMed Web of Science ®Google Scholar
• Cherubin C. E., Millian S. J. Serologic investigations in narcotic addicts. I. Syphilis, lymphogranuloma venereum, herpes simplex, and Q fever. Ann. Intern. Med. 1968; 69: 739–742
   PubMed Web of Science ®Google Scholar
• Dowdle W. Presented at the meeting AIDS: Corporate America Responds, Sponsored by Allstate Insurance Company. 1987. Chicago, IL October, 1987
   Google Scholar
• Fiorini G., Marinig C, Riboli P., Onida L., Aversa A. M., Renoldi P., Marini U., Gibelli A. AIDS-like immunologic alterations in clinically unaffected drug users. Am. J. Clin. Pathol. 1985; 84: 354–357
   PubMedGoogle Scholar
• Francis D. P., Hadler S. C., Prendergast T. J., Peterson E., Ginsberg M. M., Lookabaugh C, Holmes J. R., Maynard J. E. Occurrence of hepatitis A, B, and non-A/non-B in the United States. Sentinel county hepatitis study I. Am. J. Med. 1984; 76: 69–74
   PubMed Web of Science ®Google Scholar
• Friedland G. H., Harris C, Butkus-Small C, Shine D., Moll B., Dar-Row W., Klein R. S. Intravenous drug abusers and the acquired immunodeficiency syndrome (AIDS). Demographic, drug use, and needle sharing patterns. Arch. Intern. Med. 1985; 145: 1413–1417
   PubMed Web of Science ®Google Scholar
• Friedmann C. T.H., Dover A. S., Roberto R. R., Kearns O. A. A malaria epidemic among hexoing users. Am. J. Trop. Med. Hyg. 1973; 22: 302–307
   PubMed Web of Science ®Google Scholar
• Ginzburg H. M. Intravenous drug users and the acquired immune deficiency syndrome. Public Health Rep. 1984; 99: 206–212
   PubMed Web of Science ®Google Scholar
• Ginzburg H. M., Weiss S. H. Blood counts in male parenteral drug users. J. Am. Med. Assoc. 1985; 253: 514
   PubMed Web of Science ®Google Scholar
• Ginzburg H. M., Weiss S. H., Mac Donald M. G., Hubbard R. L. HTLV-III exposure among drug users. Cancer Res (Suppl). 1985; 45: 4605s–4608s
   Google Scholar
• Gorodetzky C. W., Sapira J. D., Jasinski D. R., Martin W. R. Liver disease in narcotic addicts. I. The role of the drug. Clin. Pharmacol. Ther. 1968; 9: 720–724
   PubMed Web of Science ®Google Scholar
• Harmon J., Aliapoulios M. A. Gynecomastia in marihuana users. N. Engl. J. Med. 1972; 287: 936
   PubMed Web of Science ®Google Scholar
• Hayward A. R. Lymphocyte disorders. Blood and Its Disorders2nd ed., R. M. Hardisty, J. D. Weatherall. Blackwell Scientific Publications, OxfordEngland 1981; 675–677
   Google Scholar
• Hollinger F. B., Khan N. C., Oefinger P. E., Yawn D. H., Schmulen A. C., Dressman G. R., Melnick J. L. Posttransfusion hepatitis type A. J. Am. Med. Assoc. 1983; 250: 2313–2317
   PubMed Web of Science ®Google Scholar
• IMMUNIZATION PRACTICES ADVISORY COMMITTEE. Recommendations for protection against viral hepatitis. M.M.W.R. 1985; 34: 313–335
   PubMedGoogle Scholar
• IMMUNIZATION PRACTICES ADVISORY COMMITTEE. Update on hepatitis B prevention. M.M.W.R. 1987; 36: 353–366
   PubMedGoogle Scholar
• Kaufman R. E., Weiss S., Moore J. D., Falcone V., Weisner R. Biological false-positive serological tests for syphilis among drug addicts. Br. J. Vener. Dis. 1974; 50: 350–353
   PubMedGoogle Scholar
• Koike T., Sueishi M., Funaka H., Tomioka H., Yoshida S. Antiphospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus. Clin. Exp. Immunol. 1984; 56: 193–199
   PubMed Web of Science ®Google Scholar
• Lange W. R., Haertzen C. A., Hickey J. E., Synder F. R., Dax E. M., Jaffe J. H. Nitrite inhalants: Patterns of abuse in Baltimore and Washington, D.C. Am. J. Drug Alcohol Abuse. 1988; 14: 29–39
   PubMed Web of Science ®Google Scholar
• Lange W. R., Snyder F. R., Lozovsky D., Kaistha V., Kaczaniuk M. A., Jaffe J. H. HIV infection in Baltimore: Antibody seroprevalence rates among parenteral drug abusers and prostitutes. Maryland Med. J. 1987; 36: 757–761
   PubMedGoogle Scholar
• Lazzarin A., Mella L., Trombini M., Umberti-Foppa C, Franzetti F., Mazzoni G., Galli M. Immunological status in heroin addicts: Effects of methadone maintenance treatment. Drug Alcohol Depend. 1984; 13: 117–123
   PubMed Web of Science ®Google Scholar
• Lemon S. M. Type A viral hepatitis. New developments in an old disease. N. Engl. J. Med. 1985; 313: 1059–1067
   PubMed Web of Science ®Google Scholar
• Lyman D. O., Boese R. J., Shearer L. A. Malaria among heroin users. Health Serv. Rep. 1972; 87: 545–549
   PubMedGoogle Scholar
• Maayan S., Wormser G. P., Hewlett D., Miller S. N., Duncanson F. P., Rodriguez A., Perla E. N., Koppel B., Rieber E. E. Acquired immunodeficiency syndrome (AIDS) in an economically disadvantaged population. Arch. Intern. Med. 1985; 145: 1607–1612
   PubMedGoogle Scholar
• Marmor M., Desjarlais D. C., Friedman S. R., Lyden M., El-Sadr W. The epidemic of acquired immunodeficiency syndrome (AIDS) and suggestions for its control in drug users. J. Substance Abuse Treat. 1984; 1: 237–247
   PubMedGoogle Scholar
• Drug addiction and the U.S. Public Health Service. Proceedings of symposium commemorating the 40th anniversary of the Addiction Research Center, Lexington, KY, 1978, W. R. Martin, I. Isbell. U.S. Government Printing Office, Washington, DC 1978; 325, DHEW publ. no. [ADM] 77–434
   Google Scholar
• Millian S. J., Cherubin C. E. Serologic investigations in narcotic addicts. III. Latix fixation, C-reactive protein, “Monotest,” serum proteins, and SH antigen. Am. J. Clin. Pathol. 1971; 56: 693–698
   PubMed Web of Science ®Google Scholar
• Nair M. P.N., Laing T. J., Schwartz S. A. Decreased natural and antibody-dependent cellular cytotoxic activities in intravenous drug abusers. Clin. Immunol. Immunopathol. 1986; 38: 68–78
   PubMedGoogle Scholar
• Ostor A. G. The medical complications of narcotic addiction-I. Med. J. Aust. 1977; 1: 410–415
   PubMedGoogle Scholar
• Rabin B. S., D'Amanda C. Immunoglobulin alterations associated with heroin addiction. Clin. Exp. Immunol. 1973; 14: 359–363
   PubMed Web of Science ®Google Scholar
• Reddy M. M., Englard A., Brown D., Buimorici-Klien E., Grieco M. H. Lymphoproliferative responses to human immunodeficiency virus antigen in asymptomatic intravenous drug abusers and in patients with lymphadenopathy or AIDS. J. Infect. Dis. 1987; 156: 374–376
   PubMedGoogle Scholar
• Sapira J. D. The narcotic addict as a medical patient. Am. J. Med. 1968; 45: 555–588
   PubMed Web of Science ®Google Scholar
• Sapira J. D., Ball J. C., Penn H. Causes of death among institutionalized narcotic addicts. J. Chron. Dis. 1970; 22: 733–742
   PubMedGoogle Scholar
• Sapira J. D., Jasinski D. R., Gorodetzky C. W. Liver disease in narcotic addicts. II. The role of the needle. Clin. Pharmacol. Ther. 1968; 9: 725–739
   PubMed Web of Science ®Google Scholar
• Sattin R. W., Roisin A., Kafrissen M. E., Dugan J. B., Farer L. S. Epidemic of gynecomastia among illegal Haitian entrants. Public Health Rep. 1984; 99: 504–510
   PubMedGoogle Scholar
• Scheutz F., Skinhoj P., Mark I. Viral hepatitis among parenteral drug addicts attending a Danish addiction clinic. Scand. J. Infect. Dis. 1983; 15: 139–143
   PubMed Web of Science ®Google Scholar
• Simpson D. D., Curtis B., Butler M. C. Description of drug users in treatment: 1971–1972 DARP admissions. Am. J. Drug Alcohol Abuse 1975; 2: 15–28
   PubMed Web of Science ®Google Scholar
• Sundkvist T., Johansson B., Widell A. Rectum carried drugs may spread hepatitis A among drug addicts. Scand. J. Infect. Dis. 1985; 17: 14
   Google Scholar
• Szmuness W., Dienstag J. L., Purcell R. H., Harley E. J., Stevens C. E., Wong D. C. Distribution of antibody to hepatitis A antigen in urban adult populations. N. Engl. J. Med. 1976; 295: 755–759
   PubMed Web of Science ®Google Scholar
• Tor J., Junca J., Ginesea C, Rey-Joly C., Foz M. T-Lymphocyte subsets in hospitalized drug abusers: Is there more than meets the eye?. Arch. Intern. Med. 1985; 145: 2134–2136
   PubMedGoogle Scholar
• Vogel H., Cherubin C. E., Millian S. J. Febrile agglutinins in narcotic addicts. Am. J. Clin. Pathol. 1970; 53: 932–935
   PubMed Web of Science ®Google Scholar
• Weppner R. S., Agar M. H. Immediate precursors to heroin addiction. J. Health Soc. Behav. 1971; 12: 10–18
   PubMed Web of Science ®Google Scholar
• Widell A., Hansson B. G., Moestrup T., Nordenfeldt E. Increased occurrence of hepatitis A with cyclic outbreaks among drug addicts in a Swedish community. Infection 1983; 1: 198–200
   Google Scholar